Holding(s) in Company

Summary by AI BETAClose X

Thomas Grant Nominees Limited, based in Leicester, UK, notified a change in the breakdown of voting rights in Shortwave Life Sciences Plc on August 18, 2025, resulting in a total holding of 4.71% or 26,800,469 voting rights. This represents an increase from their previous holding of 3.53% (14,500,469 voting rights). The increase is attributed to the acquisition of 12,300,000 additional shares, specifically 28,600,469 ordinary shares with ISIN code GB00BL6CJQ54, resulting in a 4.71% direct holding. The ultimate controlling entity is Peterhouse Capital Limited, holding 4.71% of the voting rights.

Disclaimer*

UK 100

Latest directors dealings